Cite
HARVARD Citation
Highland, K. et al. (2021). Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial. Lancet. 9 (1), pp. 96-106. [Online].